About 7,585 results

ALLMedicine™ Urticaria Center

Research & Reviews  1,854 results

How bilastine is used to treat allergic rhinitis and urticaria in children.
Immunotherapy Del Río PR, Fernández FR et. al.

Dec 2nd, 2021 - Management guidelines for allergic rhinitis and urticaria recommend oral second-generation antihistamines as first-line treatment. The efficacy and safety of bilastine, the newest nonsedating second-generation antihistamine, are well established i...

Cutaneous Cold Weather Injuries in the US Military.
Cutis Kowtoniuk RA, Liu YE et. al.

Dec 1st, 2021 - Service members of the US Military are at risk for cutaneous cold weather injuries due to the demands of military training, combat operations, and peacekeeping missions. In this article, we review common cutaneous cold weather injuries likely to b...

Nutrition and urticaria.
Clinics in Dermatology; Shao K, Feng H

Nov 27th, 2021 - Urticaria is a distressing dermatologic condition for many. Although the wheals of urticaria are characteristically evanescent, lasting less than 24 hours, patients tend to have recurrent episodes. Hives that last less than 6 weeks are considered ...

Dietary strategies for chronic spontaneous urticaria: an evidence-based review.
International Journal of Dermatology; Podder I, Jaiswal S et. al.

Nov 27th, 2021 - Although the relationship between diet and chronic spontaneous urticaria (CSU) remains elusive, several patients seek dietary modifications as they are easy and cost-effective. Adequate patient education and counseling are crucial as modified diet...

Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-...
Dermatologic Therapy; Pourani MR, Shahidi Dadras M et. al.

Nov 26th, 2021 - Considering the emergency approval of the Food and Drug Administration for widespread use of coronavirus disease 2019 (COVID-19) vaccines, evaluating potential vaccine-related adverse effects is critical as it will allow physicians to diagnose and...

see more →

Guidelines  6 results

Considerations on biologicals for patients with allergic disease in times of the COVID-...
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.
Allergy Zuberbier T, Asero R et. al.

Sep 24th, 2009 - This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: definition, classification and diagno...

see more →

Drugs  822 results see all →

Clinicaltrials.gov  78 results

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

Nov 11th, 2021 - The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)

Oct 6th, 2021 - The aim of this study is to investigate the use of benralizumab as treatment for patients with chronic spontaneous urticaria (CSU) who are symptomatic despite the use of antihistamines. It is proposed that benralizumab will deplete eosinophils and...

A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

Sep 17th, 2021 - This is a Phase 3 multi-center, open-label, single arm study investigating the safety, tolerability and efficacy of remibrutinib in participants with CSU inadequately controlled by second generation H1-antihistamines. Inadequate control of CSU by ...

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Sep 16th, 2021 - This is a multicenter, randomized, double-blind study to demonstrate similar efficacy and safety of TEV-45779 compared to XOLAIR administered sc at doses of 300 mg or 150 mg every 4 weeks for 24 weeks (6 treatments) in patients with Chronic Idiopa...

see more →

News  269 results

Contact Allergy to Topical Medicaments, Part 1: A Double-edged Sword
Ashley Ng, BS, Amber Reck Atwater, MD et. al.

Nov 8th, 2021 - Topical medications frequently are prescribed in dermatology and provide the advantages of direct skin penetration and targeted application while typically sparing patients from systemic effects. Adverse cutaneous effects include allergic contact.

CD47 Blocker ALX148 Safe to Combine With Antibody Regimens, Chemotherapy in Gastric/GEJ and HNSCC

Oct 6th, 2021 - The high affinity CD47 myeloid checkpoint inhibitor ALX148 showcased favorable safety and elicited objective responses when combined with trastuzumab (Herceptin), pembrolizumab (Keytruda), and multiagent chemotherapy regimens in patients with gast...

Expert Recommendations on the Diagnosis and Management of Long COVID

Oct 5th, 2021 - It is estimated that one million people in the UK are currently living with long COVID, and with the total number of UK COVID-19 cases nearing 8 million, the further implications of long COVID for patients and healthcare services is uncertain. As ...

COVID-19: 2 More Cases of Mucosal Skin Ulcers Reported in Male Teens

Sep 22nd, 2021 - Irish dermatologists are reporting two more cases of a rare skin ulcer known as reactive infectious mucocutaneous eruption (RIME) in teenage males who were infected with COVID-19. A similar case in an adolescent, also with ulcers affecting the mou...

Study Finds Most Adverse Events From Microneedling Are Minimal

Sep 9th, 2021 - Most adverse events associated with the practice of microneedling are transient, and most adverse effects and allergic reactions occur in conjunction with combination therapies, according to the results of a systematic review of nearly 3,000 patie...

see more →

Patient Education  5 results see all →